Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
EXPLORE-Xa: Betrixaban in Non-Valvular Atrial Fibrillation
NCT00742859Phase 2Completed
- Sponsor
- Portola Pharmaceuticals
- Start
- Oct 2008
- Primary completion
- Aug 2009
- Modality
- Small Molecules
- Countries
- 2
01
Overview
A Phase 2 trial of betrixaban in Atrial fibrillation (AFib), sponsored by Portola Pharmaceuticals. Started Oct 2008; status: completed.
02
Drugs
betrixaban
03
Conditions
Atrial fibrillation (AFib)
Beyond the preview
Go deeper on NCT00742859.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00742859.